The growing global aging population has led to an elevated prevalence of chronic diseases. This demographic shift is fueling an increasing demand for pharmaceutical products and services. Moreover, the pharmaceutical industry tends to be less susceptible to economic turbulence, offering stability to companies operating within this space.
In such a scenario, owning the shares of these three fundamentally sound pharma stocks could prove to be beneficial for investors.
This post originally appeared at StockNews.com.